SCHEMBL31301396

SCHEMBL31301396

COc1ccc(N(C)C(=O)c2ncn(-c3ccc(OC)cc3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.46
TP53 P04637 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
POLB P06746 1/20 0.46
HSP90AA1 P07900 1/20 0.44
PDK1 Q15118 1/20 0.44
PDK2 Q15119 1/20 0.44
PDK3 Q15120 1/20 0.44
PDK4 Q16654 1/20 0.44
MCHR1 Q99705 2/20 0.43
NOTUM Q6P988 1/20 0.42
ALDH1A1 P00352 2/20 0.40
HTT P42858 2/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
ALOX12 P18054 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31301359 0.95 MAPT (0.43) MAPTTP53SMN1; SMN2POLBHSP90AA1
SCHEMBL31301460 0.95 MAPT (0.43) MAPTTP53SMN1; SMN2POLBHSP90AA1
SCHEMBL31301263 0.94 GPBAR1 (0.47) MAPTTP53SMN1; SMN2POLBHSP90AA1
SCHEMBL31301336 0.94 GPBAR1 (0.47) MAPTTP53SMN1; SMN2POLBHSP90AA1
SCHEMBL31301367 0.92 TP53 (0.41) MAPTTP53SMN1; SMN2POLBHSP90AA1
SCHEMBL31301534 0.92 MCHR1 (0.43) MAPTTP53SMN1; SMN2POLBHSP90AA1
SCHEMBL31301314 0.90 TP53 (0.43) MAPTTP53SMN1; SMN2POLBHSP90AA1
SCHEMBL31301339 0.86 HSD17B2 (0.47) MAPTTP53SMN1; SMN2POLBLMNA
SCHEMBL31301351 0.85 MAPT (0.43) MAPTTP53SMN1; SMN2POLBNOTUM
SCHEMBL31301491 0.84 NOTUM (0.44) MAPTTP53SMN1; SMN2POLBNOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727549-A2 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS University of Georgia Research Foundation, Inc. (US) 2026-04-22 EP disclosed
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS UNIV GEORGIA (US) 2026-04-09 US disclosed
WO-2024258900-A2 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2024-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS SUB1, PFN1, HCCS MAPT 4575/4885TP53 4222/4885SMN1; SMN2 4264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.